secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0000926617-24-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health 2023 rev $9.2M (+15% YoY); cash burn halved to $15.9M
---------------------------------------------------------------------------

- Q4 product revenue $2.1M flat YoY; OvaSuite volume ~5,659 tests.
- Full year 2023 OvaSuite volume 23,990 units (+12% YoY); AUP $382.
- Cash used in operations $15.9M for 2023, down 49% from $31.1M in 2022.
- Gross margin improved to 57.5% from 52.8% on lower lab/shipping costs.
- Raised $5.5M in registered direct offering post year-end; cash $2.9M at Dec 31.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661724000009/0000926617-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661724000009/awh-20240328x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer